uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Future aspects of somatostatin-receptor-mediated therapy.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. Onkologisk endokrinologi. (Öberg)
2004 (English)In: Neuroendocrinology, ISSN 0028-3835, Vol. 80 Suppl 1, 57-61 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 80 Suppl 1, 57-61 p.
Keyword [en]
Antigens; CD31/metabolism, Binding Sites, Gastrointestinal Neoplasms/*drug therapy/metabolism, Humans, Neuroendocrine Tumors/*drug therapy/metabolism, Pancreatic Neoplasms/*drug therapy/metabolism, Receptors; Somatostatin/agonists/antagonists & inhibitors/classification/*physiology, Somatostatin/*analogs & derivatives/chemistry/pharmacokinetics/*therapeutic use
URN: urn:nbn:se:uu:diva-69995PubMedID: 15477719OAI: oai:DiVA.org:uu-69995DiVA: diva2:97906
Available from: 2005-06-01 Created: 2005-06-01 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Oberg, Kjell
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 106 hits
ReferencesLink to record
Permanent link

Direct link